Download
pone.0238678.pdf 761,63KB
WeightNameValue
1000 Titel
  • Assessing the potential impact of COVID-19 on life expectancy
1000 Autor/in
  1. Marois, Guillaume |
  2. Muttarak, Raya |
  3. Scherbov, Sergel |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-09-17
1000 Erschienen in
1000 Quellenangabe
  • 15(9):e0238678
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1371/journal.pone.0238678 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498023/ |
1000 Ergänzendes Material
  • https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238678#sec011 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: The COVID-19 virus pandemic has caused a significant number of deaths worldwide. If the prevalence of the infection continues to grow, this could impact life expectancy. This paper provides first estimates of the potential direct impact of the COVID-19 pandemic on period life expectancy. METHODS: From the estimates of bias-adjusted age-specific infection fatality rates in Hubei (China) and a range of six prevalence rate assumptions ranging from 1% to 70%, we built a discrete-time microsimulation model that simulates the number of people infected by COVID-19, the number dying from it, and the number of deaths from all causes week by week for a period of one year. We applied our simulation to four broad regions: North America and Europe; Latin America and the Caribbean; Southeastern Asia; and sub-Saharan African. For each region, 100,000 individuals per each 5-year age group are simulated. RESULTS: At a 10% COVID-19 prevalence rate, the loss in life expectancy at birth is likely above 1 year in North America and Europe and in Latin America and the Caribbean. In Southeastern Asia and sub-Saharan Africa, one year lost in life expectancy corresponds to an infection prevalence of about 15% and 25%, respectively. Given the uncertainty in fatality rates, with a 50% prevalence of COVID-19 infections under 95% prediction intervals, life expectancy would drop by 3 to 9 years in North America and Europe, by 3 to 8 years in Latin America and the Caribbean, by 2 to 7 years in Southeastern Asia, and by 1 to 4 years in sub-Saharan Africa. In all prevalence scenarios, as long as the COVID-19 infection prevalence rate remains below 1 or 2%, COVID-19 would not affect life expectancy in a substantial manner. INTERPRETATION: In regions with relatively high life expectancy, if the infection prevalence threshold exceeds 1 or 2%, the COVID-19 pandemic will break the secular trend of increasing life expectancy, resulting in a decline in period life expectancy. With life expectancy being a key indicator of human development, mortality increase, especially among the vulnerable subgroups of populations, would set a country back on its path of human development.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Respiratory infections
lokal Asia
lokal Life expectancy
lokal Europe
lokal Age groups
lokal Death rates
lokal Pandemics
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-2701-6286|https://frl.publisso.de/adhoc/uri/TXV0dGFyYWssIFJheWE=|https://frl.publisso.de/adhoc/uri/U2NoZXJib3YsIFNlcmdlbA==
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. Assessing the potential impact of COVID-19 on life expectancy
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6426617.rdf
1000 Erstellt am 2021-04-01T13:53:55.640+0200
1000 Erstellt von 5
1000 beschreibt frl:6426617
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Wed May 05 10:32:37 CEST 2021
1000 Objekt bearb. Wed May 05 10:32:27 CEST 2021
1000 Vgl. frl:6426617
1000 Oai Id
  1. oai:frl.publisso.de:frl:6426617 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source